There is a continuously growing demand for circumference reduction and body shaping technologies, with an overwhelming preference for non-invasive, pain-free procedures. This paper presents a novel body contouring device which uses pulsed, vacuum-assisted non-focused ultrasound. To evaluate the clinical safety and efficacy of the vacuum-assisted acoustic wave technology for circumference reduction of the abdominal region. Eighteen healthy women with a body mass index under 25 underwent four 20-min fat reduction treatments in the abdominal region, at 1-week intervals. Efficacy was evaluated by the change in abdominal circumference up to 12 weeks post treatment relative to baseline and by comparison of before and after photos by two blinded evaluators. Subjects rated their satisfaction with the treatment procedure and outcomes. Safety was evaluated by adverse events, local skin reaction, and pain assessments. 1 week after the final session, the mean reductions in abdominal circumference measured 5.4 ± 2.6 cm. At 1 month after the last session, the cumulative reduction in circumference was 5.8 ± 3.2 cm. Measurements take at 3 months after the last treatment showed abdominal circumferences decrease of an average 5.2 ± 3.1 cm relative to baseline measures. All patients reported a painless procedure and there were no treatment-induced severe adverse events. Most patients reported a positive change in body contour, with all subjects saying they would highly recommend the treatment to others. Assessments performed by blinded evaluators ranked six cases as very to extremely improved and an additional seven cases as somewhat improved. No dramatic weight fluctuations were recorded. This study demonstrates that a four-treatment course with an acoustic wave ultrasound applicator with 1-week intervals, leads to a significant reduction in abdominal circumference, lasting up to at least 3 months with no pain or side effects reported.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/dth.15101 | DOI Listing |
J Infect Dis
January 2025
Department of Internal Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Background: In people with HIV (PWH) who are virally suppressed (VS) on antiretroviral therapy (ART), abdominal obesity (AO) is linked to neurocognitive impairment (NCI), potentially due to visceral adiposity, inflammation, and reduced insulin-like growth factor 1 (IGF-1). Tesamorelin, a growth hormone-releasing hormone, reduces AO and increases IGF-1, suggesting it might mitigate NCI in VS PWH.
Methods: This 6-month, Phase II randomized, open-label clinical trial compared Tesamorelin versus standard-of-care (SOC) for NCI in abdominally obese PWH.
Background: Bariatric surgeries, such as laparoscopic sleeve gastrectomy (LSG), not only result in significant weight loss but also improve the inflammatory state in obese patients. This study aimed to investigate the effects of LSG on weight loss and inflammation status in bariatric patients 1-year post-procedure.
Methods: This prospective cohort study was conducted from September 2022 to May 2024.
Plast Reconstr Surg Glob Open
January 2025
From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Background: Most patients undergoing breast surgery with free nipple grafts lose nipple erection (NE) function. This study aimed to evaluate the effect of nerve preservation and reconstruction with targeted nipple-areola complex reinnervation (TNR) on NE following gender-affirming mastectomy with free nipple grafting.
Methods: Patients undergoing gender-affirming mastectomy with free nipple grafts were prospectively enrolled.
J Diabetes Sci Technol
January 2025
Madras Diabetes Research Foundation, Chennai, India.
Introduction: mHealth technology has the potential to deliver personalized health care; however, data on cardiometabolic risk factors are limited. This study aims to assess the effectiveness of mobile health applications (apps) on cardiometabolic risk factor reduction in adults aged 25 to 60 years in urban and rural India.
Methods: The study design was a pilot randomized controlled trial conducted in Tamil Nadu, India.
BMC Public Health
January 2025
Department of Pediatrics, Faculty of Medicine, Universiti Malaya, Wilayah Persekutuan Kuala Lumpur, 50603, Kuala Lumpur, Malaysia.
Background: Recently, there has been an increase in the prevalence of childhood obesity in Malaysia, raising concerns about increased cardiometabolic morbidity. MyBFF@school is a multifaceted program comprising physical activity, nutritional education, and psychological empowerment introduced to combat childhood obesity in Malaysia. The efficacy of a six-month intervention on the body composition of overweight and obese primary schoolchildren was evaluated.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!